AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2021
Feb 11, 2021
32552_dirs_2021-02-10_729a81f1-5b63-461c-8fd8-170626c46ccf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-02-09
Reporting Person: Schobel Alexander Mark (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-09 | Common Stock | S | 11540 | $6.75 | Disposed | 860460 | Direct |
| 2021-02-10 | Common Stock | S | 23460 | $6.75 | Disposed | 837000 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17